SC16 Schedule

10:10 Tuesday, November 15

12:10 Thursday, November 17

ByteGrid and MAX Enabling Super Computing with High Capacity Data Center and Networks

ByteGrid's CTO, Jason Silva, will discuss how Life Sciences and Research and Education can leverage the terabit advanced networking infrastructure resources within ByteGrid's Silver Spring, Maryland colocation facility.

The MAX regional network provides extremely high-speed access to the larger national and global R&E network infrastructure, including multiple 100-Gbps connections to the Internet2 network and other high-performance wide area network infrastructures. MAX and ByteGrid's partnership provides a much-needed resource to members of the local life sciences research community by helping them integrate massive storage archives (typically involving petabytes of data) with high-performance compute and network requirements.

Mr. Silva will give an overview of the data center facility, its compliance alignment and discuss the best manner for interested Life Sciences and R&E to leverage the high speed cyberplatform. Mr. Silva will also provide insights into future projects between the two organizations.

Speaker Bio - Jason Silva

Jason Silva is President and Chief Technology Officer at ByteGrid. Jason has over 17 years experience in Data Center Management and Information Technology. His experience includes the management and implementation of internet and intranet systems in the healthcare, pharmaceutical, government, and technology sectors. Jason joined ByteGrid in March of 2015 when his former company Sidus Data was acquired by ByteGrid. Jason was a Founding Partner and Chief Executive Officer of Sidus. Jason's main focus as Chief Technology Officer is building, supporting and advancing ByteGrid's product portfolio as the most innovative information systems available to today's enterprises. He has spoken extensively on the implementation of regulated cloud computing environments to national and international industry groups such as the International Society of Pharmaceutical Engineers (ISPE) and Institute for Validation Technology. Mr. Silva has also participated and presented to the FDA's cloud working group on the risk considerations and data integrity for regulated cloud deployments.